Ranpirnase – an antitumour ribonuclease: its potential role in malignant mesothelioma
Authors:
- 21 March 2006
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Biological Therapy
- Vol. 6 (4) , 391-399
Abstract
(2006). Ranpirnase – an antitumour ribonuclease: its potential role in malignant mesothelioma. Expert Opinion on Biological Therapy: Vol. 6, No. 4, pp. 391-399. doi: 10.1517/14712598.6.4.391Keywords
This publication has 32 references indexed in Scilit:
- Asbestos and mesothelioma: Worldwide trendsLung Cancer, 2005
- Surgical management of malignant pleural mesothelioma: a systematic review and evidence summaryLung Cancer, 2005
- Epidemiology, biologic behavior, and natural history of mesotheliomaThoracic Surgery Clinics, 2004
- Chemotherapy for malignant pleural mesothelioma: past results and recent developmentsLung Cancer, 2004
- Pathogenesis of Malignant MesotheliomaClinical Lung Cancer, 2004
- Integration of Multimodality Approaches in the Management of Malignant Pleural MesotheliomaClinical Lung Cancer, 2004
- New developments about the association of SV40 with human mesotheliomaOncogene, 2003
- Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural MesotheliomaJournal of Clinical Oncology, 2003
- Activity of chemotherapy and immunotherapy on malignant mesothelioma: a systematic review of the literature with meta-analysisLung Cancer, 2002
- Multimodality treatment of diffuse malignant pleural mesotheliomaSeminars in Oncology, 2002